Personalized Approach to Cancer Therapy Leads to Improved Outcomes
A personalized approach to cancer therapy leads to improved outcomes in a wide variety of cancers.
Personalized cancer therapy correlated with higher response rates, prolonged progression-free survival, and overall survival of cancer patients when compared to non-personalized approaches, in a meta-analysis of more than 330,000 patients enrolled in clinical trials.
Schwaederle M, Zhao M, Lee JJ, Eggermont AM, Schilsky RL, Mendelsohn J, Lazar V, Kurzrock R. Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials. J Clin Oncol. 2015 Nov 10;33(32):3817-25.
Link to article in Journal of Clinical Oncology